Fadia T. Shaya， Wallace Johnson， Anna Gu， Elijah Saunders Pharmaceutical Health Services Research， University of Maryland， School of Pharmacy， Baltimore， MD; Epidemiology and Preventive Medicine， University of Ma.....
Center for Cardiovascular Disease Prevention， Department of Medicine， Brigham and Women"s Hospital， Harvard Medical School， Boston， Mass， USA. pridker@partners.orgIncreased levels of high-sensitivity C-reactive p.....
Am J Med 15 Oc 2004， 117（8 ）： 596-606 Matthias Briel， ， Marco Studer， ， Tracy R. Glass， ， Heiner C. Bucher， a，* Purpose To assess if lipid-lowering interventions (statins， fibrates， resins， n-3 fatty acids.....
Lancet. 2004 Aug 21;364(9435):685-96. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled .....
Major outcomes in moderately hypercholesterolemic， hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Hear.....
关注公众号
安卓客户端
